mdxhealth
Michael Lipps, with experience in regulatory affairs and quality systems in the genetics and biotechnology industry, has held various key roles such as Vice President at mdxhealth and Associate Director at Ambry Genetics. With a strong background in molecular biology and biotechnology, Michael has effectively streamlined operations, overseen regulatory submissions, and enhanced quality assurance processes. Michael's expertise in managing laboratory operations and implementing new technologies has significantly improved efficiency and productivity in various roles throughout their career.
mdxhealth
Mdxhealth is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The company's tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, and prediction of response to a specific therapy. The Company's European headquarters are in Herstal, Belgium, with laboratory operations in Nijmegen, The Netherlands, and US headquarters and laboratory operations based in Irvine, California.